Company / Current Assets per Share
Astria Therapeutics, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.96
FY2024
5-year range
$5.96 / $15.57
FY2020-FY2024
Trend
-28.5%
vs FY2023
Sector context
#121 of 210
Health Care
What the data says
At $5.96, Astria Therapeutics, Inc.'s current assets per share ranks #121 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $2.44 in FY2016 to $15.57 in FY2022.
Based on SEC 10-K filings.
5.96 in FY2024 with a 5-year CAGR of +8.2%.
Declined from $15.57 to $5.96 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -25.2%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
#121 of 210 in Health CareTop 58% of 210This company $5.96 Sector average $170.65
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2024, current assets per share decreased 28.5% year-over-year.
- Ranks #121 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.96 | -28.5% |
| FY2023 | $8.33 | -46.5% |
| FY2022 | $15.57 | +9.4% |
| FY2021 | $14.24 | -6.0% |
| FY2020 | $15.15 | +276.6% |
| FY2019 | $4.02 | -47.8% |
| FY2018 | $7.70 | -4.4% |
| FY2017 | $8.05 | +230.7% |
| FY2016 | $2.44 | -69.2% |
| FY2015 | $7.90 | -77.7% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026